CVE-2024-45412

Public Exploit
Yeti affected by a Potential Denial of Service due to the One Milion Unicode characters attack

Description

Yeti bridges the gap between CTI and DFIR practitioners by providing a Forensics Intelligence platform and pipeline. Remote user-controlled data tags can reach a Unicode normalization with a compatibility form NFKD. Under Windows, such normalization is costly in resources and may lead to denial of service with attacks such as One Million Unicode payload. This can get worse with the use of special Unicode characters like U+2100 (℀), or U+2105 (℅) which could lead the payload size to be tripled. Versions prior to 2.1.11 are affected by this vulnerability. The patch is included in 2.1.11.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.60%
Vendor Advisory github.com
Affected: yeti-platform yeti
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-45412?
CVE-2024-45412 has been scored as a medium severity vulnerability.
How to fix CVE-2024-45412?
To fix CVE-2024-45412, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-45412 being actively exploited in the wild?
It is possible that CVE-2024-45412 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-45412?
CVE-2024-45412 affects yeti-platform yeti.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.